SCHEMBL3028022

SCHEMBL3028022

COC(=O)c1c(Br)c2ccc(O)cc2n1C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ GABRG2 P18507 2/20 0.35
▸ GABRB3 P28472 2/20 0.35
▸ GABRA5 P31644 2/20 0.35
▸ CA12 O43570 3/20 0.35
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ CA7 P43166 3/20 0.35
▸ CA9 Q16790 3/20 0.35
▸ CA14 Q9ULX7 3/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ PDK4 Q16654 1/20 0.35
▸ NR1H2 P55055 2/20 0.35
▸ MAPT P10636 4/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ PKM P14618 3/20 0.34
▸ HPGD P15428 2/20 0.34
▸ ALOX15 P16050 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30220573 0.87 MAPK14 (0.35) GABRG2GABRB3GABRA5NR1H2MAPT
SCHEMBL20569550 0.83 HDAC2 (0.40) NR1H2MAPTKDM4E
SCHEMBL3030930 0.82 GABRG2 (0.34) GABRG2GABRB3GABRA5CA12CA1
SCHEMBL3027549 0.77 NR1H2 (0.36) GABRG2GABRB3GABRA5NR1H2MAPT
SCHEMBL20569958 0.74 HDAC2 (0.38) GABRG2GABRB3GABRA5NR1H2ALDH1A1
SCHEMBL3024003 0.73 NR1H2 (0.45) HTR6ESR2CA12CA1CA2
SCHEMBL20571060 0.73 PLA2G2A (0.40) NR1H2MDM2MAPK8
SCHEMBL20915455 0.72 KDM4E (0.40) GABRG2GABRB3GABRA5NR1H2KDM4E
SCHEMBL29595329 0.72 KDM4E (0.40) GABRG2GABRB3GABRA5NR1H2KDM4E
SCHEMBL1179770 0.72 HTR6 (0.46) HTR6ESR2GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 — — US disclosed
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 — — US disclosed
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 — — US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 — — US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 — — US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 — — US disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 HTR6 3664/4885ESR2 3407/4885GABRG2 4552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback